Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
02/02/2011 | CN101133166B Making nucleic acid sequences in parallel and use |
02/01/2011 | US7880059 Production of proanthocyanidins to improve forage quality |
02/01/2011 | US7880058 Cis-prenyltransferases from plants |
02/01/2011 | US7880057 Precise breeding—backbone integration markers |
02/01/2011 | US7879993 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
02/01/2011 | US7879992 Modification of MyD88 splicing using modified oligonucleotides |
02/01/2011 | US7879991 CGRP binding nucleic acids |
02/01/2011 | US7879990 Polynucleotides encoding antibodies that bind to the C35 polypeptide |
02/01/2011 | US7879989 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cell proliferative disorders |
02/01/2011 | US7879988 Fluorescent proteins from Aequorea coerulscens and methods for using the same |
02/01/2011 | US7879987 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis |
02/01/2011 | US7879980 Monoclonal antibodies to human CTLA-8 (IL-17A) |
02/01/2011 | US7879812 Interfering nucleotide sequences which disrupt activation of toll-like receptors (TLR); treating autoimmune and/or allergic disorders |
02/01/2011 | US7879811 Formulations comprising antisense nucleotides to connexins |
02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
02/01/2011 | US7879608 PUFA polyketide synthase systems and uses thereof |
02/01/2011 | US7879592 Biosynthesis using genetic engineered yeasts |
02/01/2011 | US7879591 Vector comprising lysophosphatidic acid acyltransferase sequences for use in generating yeast with enhanced capacity to produce long-chain polyunsaturated fatty acids |
02/01/2011 | US7879586 Gene encoding methylated catechin synthase |
02/01/2011 | US7879585 Ketoreductase enzymes and uses thereof |
02/01/2011 | US7879581 Using 16S ribosomal RNA as diagnostic tool in screening for microbial presence in biological samples |
02/01/2011 | US7879580 Methods for high fidelity production of long nucleic acid molecules |
02/01/2011 | US7879557 Isolated fluorescent protein from Clytia gregaria CGFP and use thereof |
02/01/2011 | US7879554 Electrochemical method to measure DNA attachment to an electrode surface in the presence of molecular oxygen |
02/01/2011 | US7879552 Association of UQCRC1 SNPs with fat deposition and fatty acid composition |
02/01/2011 | US7879551 Using presence of variation in methylenetetrahydrofolate dehydrogenase as evaluative tool in diagnosis/prognosis of pregnancy-related disorders |
02/01/2011 | US7879549 Probe, probe set, probe-immobilized carrier, and genetic testing method |
02/01/2011 | US7879546 Using human papilloma virus expression profiles as diagnostic/evaluative tool in detection viral induced neoplasia |
02/01/2011 | US7879543 Using allelic variation in factor V leiden G1691A, prothrombin and tissue factor plasma inhibitor as diagnostic and prognostic indicators of thrombosis |
02/01/2011 | US7879542 Methylated gene biomarkers for detecting cancer |
02/01/2011 | US7879330 Monoclonal antibody for use in passive immunization against botulinum intoxication; immunotherapy |
02/01/2011 | US7879328 Antibodies that immunospecifically bind to B lymphocyte stimulator |
02/01/2011 | US7879111 System and method for RFID transfer of MAC, keys |
02/01/2011 | CA2354508C Streptococcal c5a peptidase vaccine |
02/01/2011 | CA1341610C Osteogenic polypeptides |
01/27/2011 | WO2011011464A2 Constructs and methods for efficient transformation of micro-organisms for production of carbon-based products of interest |
01/27/2011 | WO2011011416A1 Compositions for use in identification of arenaviruses |
01/27/2011 | WO2011010737A1 Guide nucleic acid for cleavage of micro-rna |
01/27/2011 | WO2010141726A3 Peptide dicer substrate agents and methods for their specific inhibition of gene expression |
01/27/2011 | WO2010138328A3 Light-regulated promoters |
01/27/2011 | WO2010135514A3 Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of cytomegalovirus and epstein-barr virus |
01/27/2011 | WO2010008474A4 Methods for treating multiple sclerosis using antisense oligonucleotides |
01/27/2011 | US20110023194 Engineering zymogen for conditional toxicity |
01/27/2011 | US20110023191 Methods for improving crop plant architecture and yield |
01/27/2011 | US20110023190 Use of dimerization domain component stacks to modulate plant architecture |
01/27/2011 | US20110023187 Putative Cytokinin Receptor and Methods for Use Thereof |
01/27/2011 | US20110023184 Axmi-205 pesticidal gene and methods for its use |
01/27/2011 | US20110023183 Switchgrass Promoter and Uses Thereof |
01/27/2011 | US20110023182 Enzymes involved in triterpene synthesis |
01/27/2011 | US20110023181 Means for Improving Agrobiological Traits in a Plant by Providiing a Plant Cell Comprising in its Chloroplasts Enzymatic Activities for Converting Glycolate Into Malate |
01/27/2011 | US20110023180 Novel hydroxyphenylpyruvate dioxygenase polypeptides and methods of use |
01/27/2011 | US20110023179 Plastid transit peptides derived from lower photosynthetic eukaryotes and methods |
01/27/2011 | US20110023177 Genetically Modified Plants Displaying Reduced Accumulation of Cadmium |
01/27/2011 | US20110023156 Feline genome editing with zinc finger nucleases |
01/27/2011 | US20110023155 Novel dna fragment and use thereof |
01/27/2011 | US20110023153 Genomic editing of genes involved in alzheimer's disease |
01/27/2011 | US20110023150 Genome editing of genes associated with schizophrenia in animals |
01/27/2011 | US20110023149 Genomic editing of genes involved in tumor suppression in animals |
01/27/2011 | US20110023141 Genomic editing of genes involved with parkinson's disease |
01/27/2011 | US20110023139 Genomic editing of genes involved in cardiovascular disease |
01/27/2011 | US20110023137 Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof |
01/27/2011 | US20110023135 Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions |
01/27/2011 | US20110021790 Producing biofuels using polyketide synthases |
01/27/2011 | US20110021768 B12-Dependent Dehydratases With Improved Reaction Kinetics |
01/27/2011 | US20110021767 B12-Dependent Dehydratases With Improved Reaction Kinetics |
01/27/2011 | US20110021759 Diagnosis and Treatment of Blood Disorders |
01/27/2011 | US20110021757 Transgenic silkworm capable of producing antibody and method for production thereof |
01/27/2011 | US20110021752 Tropoelastin Derivatives |
01/27/2011 | US20110021749 Chemical Plugs used with Automated Organic Polymer Synthesizers |
01/27/2011 | US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
01/27/2011 | US20110021611 Efficient cell culture system for hepatitis c virus genotype 5a |
01/27/2011 | US20110021610 Aromatic prenyltransferase from hop |
01/27/2011 | US20110021609 MicroRNA Signatures Associated with Cytogenetics and Prognosis in Acute Myeloid Leukemia (AML) and Uses Thereof |
01/27/2011 | US20110021605 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
01/27/2011 | US20110021604 Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna |
01/27/2011 | US20110021603 TRPM-2 Antisense Therapy |
01/27/2011 | US20110021601 Composition containing microrna-21 inhibitor for enhancing radiation sensitivity |
01/27/2011 | US20110021600 Novel nucleic acid |
01/27/2011 | US20110021546 Gene Defects And Mutant ALK Kinase In Human Solid Tumors |
01/27/2011 | US20110021445 Compositions and methods for treating erectile dysfunction |
01/27/2011 | US20110021444 Compositions for controlling hair growth |
01/27/2011 | US20110021442 Cell preamble runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same |
01/27/2011 | US20110021441 Conjugate comprising p21 protein for the treatment of cancer |
01/27/2011 | US20110021430 Modified vitamin k-dependent polypeptides |
01/27/2011 | US20110021429 Renoprotection by growth hormone-releasing hormone and agonists |
01/27/2011 | US20110021412 Human Receptor Proteins; Related Reagents and Methods |
01/27/2011 | US20110021383 Apparatuses for real-time, single molecule sequence determination |
01/27/2011 | US20110021382 siRNA targeting amyloid beta (A4) precursor protein (APP) |
01/27/2011 | US20110021378 Nucleic acids of pichia pastoris and use thereof for recombinant production of proteins |
01/27/2011 | US20110021369 Single cell based reporter assay to monitor gene expression patterns with high spatio-temporal resolution |
01/27/2011 | US20110021365 Nucleic Acid Binding Compounds Containing Pyrazolo[3,4-D]Pyrimidine Analogues of Purin-2,6-Diamine and Their Uses |
01/27/2011 | US20110021364 Predictive test for adult dog body size |
01/27/2011 | US20110020926 Novel taste-modifying polypeptide nas, dna thereof and use thereof |
01/27/2011 | US20110020911 Solubilization and purification of a target protein fused to a mutant maltose-binding protein |
01/27/2011 | US20110020907 Viruses lacking epithelial cell receptor entry |
01/27/2011 | US20110020900 Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefore |
01/27/2011 | US20110020899 Glucoamylase variants with altered properties |
01/27/2011 | US20110020896 Mutant dna polymerases and their genes |
01/27/2011 | US20110020895 Methods and compositions for determining isomerase enzymatic activity |
01/27/2011 | US20110020883 Acyl-acp thioesterase genes and uses therefor |